Sign in

CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company

SELLAS Life Sciences Group, Inc.

Sign in to watch
Ticker
SLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
6462005278
Business address
7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
Former names
GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
  1. DEFA14A Proxy Proxy Materials
  2. D Other Notice of Sales of Unregistered Securities
  3. CT ORDER Other Confidential Order
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. POS EX Other Post-effective Amendment
  6. POS EX Other Post-effective Amendment
  7. POS EX Other Post-effective Amendment
  8. POS EX Other Post-effective Amendment
  9. EFFECT Other Notice of Effectiveness
  10. EFFECT Other Notice of Effectiveness
  11. CT ORDER Other Confidential Order
  12. DEFA14A Proxy Proxy Materials
  13. EFFECT Other Notice of Effectiveness
  14. CT ORDER Other Confidential Order
  15. EFFECT Other Notice of Effectiveness
  16. CT ORDER Other Confidential Order
  17. DEFR14A Other DEFR14A
  18. DEFA14A Proxy Proxy Materials
  19. D Other Notice of Sales of Unregistered Securities
  20. EFFECT Other Notice of Effectiveness

Page 4 of 7 · 127 filings